Parallel 6 adds patient recruitment predictive modeling and patient matching capabilities to Clinical Reach – an mClinical platform for patient enrollment, engagement and management of clinical trials worldwide.
San Diego, CA (PRWEB) January 07, 2016
Parallel 6, the leading provider of mobile clinical solutions, today announced its acquisition of nPruv, Inc., the developer of a patient matching and predictive modeling solution for clinical trial patient recruitment. Terms of the transaction, which the companies completed on December 24, were not disclosed.
The growth of digital and emerging technologies make the life sciences sector one of the fastest growing markets. With the addition of nPruv’s patient matching and predictive modeling solution, Parallel 6’s Clinical Reach platform will further eliminate the time and cost of patient recruitment for clinical trial sponsors and contract research organizations (CROs). A new ‘recruitment’ module in the Clinical Reach platform allows large multi-trial organizations to quickly and securely match patient-to-trial, resulting in rapid recruitment and improved patient enrollment workflows.
The nPruv platform is fully scalable for patient recruitment campaigns of any size. The one-of-a-kind nPruv solution engages potential trial patients both at the point-of-care and online where the patient data provides real-time recruitment analytics.
“Clinical Reach is the leading mClinical platform for enrolling, engaging and managing participants in clinical trials anywhere in the world.” said CEO and Chairman of Parallel 6, Allan Camaisa. “The nPruv solution provides an excellent complement to the Parallel 6 portfolio of products, especially in the mobile clinical arena, where Parallel 6 is poised for exponential growth and expansion as our technology accelerates speed of research to bring life saving drugs and treatments to market sooner.”
On a patient level, the nPruv technology provides a ‘match.com for clinical trials’ for anyone seeking access to or who would be a good candidate for a trial. The platform provides a clinical trial marketplace for sponsors to publish consumer-friendly trial information that empowers patients to find, match, and share clinical trial opportunities for medical conditions that affect themselves, their friends and their family.
“Parallel 6’s established expertise in mobile clinical solutions, particularly in clinical trial patient engagement and management, will support ongoing development and enhancement of the nPruv system,” said Brad Pruitt, M.D., founder and Chief Executive Officer of nPruv, Inc. “Innovative technologies like nPruv and Clinical Reach by Parallel 6 improve patient recruitment data quality and patient experience while reducing recruitment time and cost.”
President, CTO and founder of Parallel 6, David Turner stated that “For patients to flow seamlessly from clinic waiting rooms to digital recruitment campaigns engaging them in real-time and at the ‘right-time’ is truly exciting. This will help to increase speed of research and reduce overall trial costs. Our recruitment analytics make proactive participant recruitment management and recruitment process streamlining achievable and more efficient through data-driven decisions by sponsors and CROs.”
To learn how Clinical Reach is leading technical innovation for clinical trials, visit http://www.parallel6.com or request a demo.
About Parallel 6
Parallel 6, is an innovative software as a service provider of mobile enrollment & engagement solutions for clinical research, health, and public sector organizations. Clinical Reach, a Parallel 6 product, is an end-to-end patient centric engagement platform for the healthcare and life sciences industries. Clinical Reach enables clinical trial stakeholders to digitally enroll, engage, record, report, and monitor clinical trial participants through their patented platform. Additional solutions include GovReach accelerates government-to-citizen and internal, government-digital efficiency, transparency, and engagement. The firm is headquartered in San Diego with federal offices in Washington D.C. For more information, visit http://www.parallel6.com/.
For the original version on PRWeb visit: http://www.prweb.com/releases/2016/01/prweb13154015.htm